Tuesday, September 18, 2018
 
 
Company News: Page (1) of 1 - 04/03/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
EMA to Review DUPIXENT® (dupilumab) as Potential Treatment for Inadequately Controlled Moderate-to-Severe Asthma
 
(April 03, 2018)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:USA, Inc.,Medicine,Disease,Insurance,healthcare,Surgery,Medication,Vitamins/Nutrition,Womens Health,Seniors Health,Seniors,Physician,Insurance Companies,Children,Science,Medical,Biology,Genetics,Cancer,Business,Science,Adults,Children,Other,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Brain Ischemia Market Analysis 2018-2023 | Increased Prevalence Rate with Topmost Players ThromboGenics, Vernalis, Neurotec Pharma, Covidien and Others - Asserts MRFR
  • Effie Chow Qigong Healing System Available On Mediterranean Celebrity Cruise Line Says Sharon Kleyne & Rose Hong
  • The Methuselah Foundation Successfully Closes its Boutique Venture Fund, the Methuselah Fund, Focused on Companies That Can Extend the Healthy Human Lifespan
  • Report on CPH by Research Dynamics: Investor Day update
  • Icahn School of Medicine Celebrates 50th Anniversary with Launch of Scientific American Custom Media Series

    Cancer
  • Sequana Medical reports positive data on use of the alfapump® in malignant ascites patients at the International Gynecologic Cancer Society
  • China Scar Treatment Market to be Valued at USD 2.77 Billion by 2025 | Hexa Research
  • Achieve Announces Positive Cytisine Data Published in International Journal of Drug Policy
  • Hair Care Industry to account for Upsurge Accruals USD 55,756.1 million till 2023 - Confirms MRFR
  • CHI Franciscan Health, Virginia Mason Announce Plan for New Birth Center in Seattle
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines